Viewing Study NCT02812706


Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2026-03-06 @ 5:57 PM
Study NCT ID: NCT02812706
Status: COMPLETED
Last Update Posted: 2024-04-01
First Post: 2016-06-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti-CD38 monoclonal antibody View